Search results
Results from the WOW.Com Content Network
List of side effects of estradiol which may occur as a result of its use or have been associated with estrogen and/or progestogen therapy includes: [1] [2]. Gynecological: changes in vaginal bleeding, dysmenorrhea, increase in size of uterine leiomyomata, vaginitis including vaginal candidiasis, changes in cervical secretion and cervical ectropion, ovarian cancer, endometrial hyperplasia ...
Hemorrhoids are common in pregnancy as a result of constipation and increased intra-abdominal pressure. Hemorrhoids can cause bleeding, pain, and itching. [32] Treatment is symptomatic, including improving underlying constipation. Symptoms may resolve spontaneously after pregnancy, although hemorrhoids may remain in the days after childbirth. [33]
[1] [46] Other side effects of progestogens may include an increased risk of breast cancer, cardiovascular disease, and blood clots, among others. [2] Some of the side effects of progestogens are due not to their progestogenic activity but rather due to off-target activities (e.g., androgenic activity, glucocorticoid activity ...
Estradiol valerate/hydroxyprogesterone caproate (EV/OHPC), sold under the brand names Gravibinon and Injectable No. 1 (or Chinese Injectable No. 1) among others, is a combined estrogen and progestogen medication which is used in the treatment of threatened miscarriage and other indications (e.g., as a means of pseudopregnancy) [1] [2] [3] and as a form of combined injectable birth control to ...
Hydroxyprogesterone caproate is generally well tolerated and produces few side effects. [1] Injection site reactions such as pain and swelling are the most common side effect of hydroxyprogesterone caproate. [1] The medication may increase the risk of gestational diabetes when used in pregnant women.
Hemorrhoids affect people most often between 45 and 65 years of age, [5] and they are more common among the wealthy, [4] although this may reflect differences in healthcare access rather than true prevalence. [13] Outcomes are usually good. [3] [9] The first known mention of the disease is from a 1700 BC Egyptian papyrus. [14]
Loperamide has limited data on the impact it has on pregnancy, but there is an association with cardiovascular malformation in the first trimester. [14] [12] Atropine/diphenoxylate currently has insufficient evidence of teratogenicity in humans, but trials with animals showed evidence of teratogenic effects. [14]
Most often, nausea and vomiting symptoms during pregnancy resolve in the first trimester, however, some continue to experience symptoms. Hyperemesis gravidarum is diagnosed by the following criteria: greater than 3 vomiting episodes per day, ketonuria, and weight loss of more than 3 kg or 5% of body weight.